Breast cancer screening slows French death rate:
This article was originally published in Clinica
Executive Summary
There has been a 7.7% decrease in the number of deaths from breast cancer between 1988 and 1999 in the ten French areas (departements) where breast screening was first introduced in the early 1990s, compared with an average decrease of 1% in all other areas. These figures are quoted by the French Daily Epidemiological Bulletin. Breast cancer screening only became introduced on a national scale last year. There are some 11,000 deaths in France from breast cancer each year, and some 42,000 new cases annually, the French medical paper, Le Quotidien du Medecin, states, and recent studies indicate that systematic screening of women between the ages of 40-60 can reduce mortality from the disease by 25-30%.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.